Chase Cornelison is a post-doctoral researcher at Virginia Tech and lead author of an article published in Scientific Reports that details a solution to stopping the spread of glioblastoma in the brain.
Research led by Chase Cornelison and Center for Engineered Health faculty Jennifer Munson, demonstrate a unique technique using a new drug called AMD3100, to stop the spread of glioblastoma in the brain.
Their detailed findings are reported in the article published on Nov. 19 in Scientific Reports.
This work is part of a Munson-led five-year research grant project across multiple universities, examining the role of interstitial fluid flow in the spread of glioma cells.